You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Grade II Glioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • +3 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 21, 2022

WHO Grade II Glioma Trial in Japan (DS-1001b)

Active, not recruiting
  • WHO Grade II Glioma
  • Nagoya, Aichi, Japan
  • +10 more
Feb 3, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)

    Completed
    • Glioblastoma Multiforme
    • Glioma of Brain
    • Chandler, Arizona
    • +2 more
    Jan 11, 2023

    Glioma, Pilocytic Astrocytoma, Pilomyxoid Astrocytoma Trial in Rochester, Memphis (Hippocampal-avoidance proton therapy)

    Recruiting
    • Glioma
    • +6 more
    • Hippocampal-avoidance proton therapy
    • Rochester, Minnesota
    • +1 more
    Aug 18, 2022

    Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

    Not yet recruiting
    • Neoplasms
    • +7 more
    • Biological G207
    • Birmingham, Alabama
      Children's of Alabama
    Jun 1, 2022

    Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

    Recruiting
    • Glioblastoma
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • Quality-of-Life
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)

    Recruiting
    • Grade 1 Glioma
    • +2 more
    • Strasbourg, France
      CHU Strasbourg - France
    Jul 7, 2022

    Malignant Glioma Trial in Nashville (Bevacizumab, Temozolomide, Vitamin C)

    Completed
    • Malignant Glioma
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Mar 9, 2022

    High Grade Glioma Trial in Toronto (Supramarginal resection, Conventional (i.e. GTR) resection)

    Recruiting
    • High Grade Glioma
    • Supramarginal resection
    • Conventional (i.e. GTR) resection
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    May 5, 2022

    Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

    Not yet recruiting
    • Advanced Solid Tumor
    • +2 more
    • Palo Alto, California
    • +9 more
    Aug 2, 2022

    High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

    Recruiting
    • High Grade Glioma
    • +12 more
    • LUTATHERA® (Lutetium Lu 177 dotatate)
    • Aurora, Colorado
    • +8 more
    Jan 16, 2023

    Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2022

    Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

    Recruiting
    • Glioblastoma
    • Concurrent CRT Period
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University/Johns Hopkins Hospital
    Mar 2, 2023

    Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)

    Not yet recruiting
    • Brain Tumor
    • Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Recurrent High-grade Glioma Trial in France (AsiDNA)

    Recruiting
    • Recurrent High-grade Glioma
    • Angers, France
    • +9 more
    Sep 2, 2022

    Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

    Terminated
    • Low Grade Glioma
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Nov 3, 2021

    Glioma, Glioblastoma Trial in Winston-Salem (Soliramfetol)

    Recruiting
    • Glioma
    • Glioblastoma
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Jan 31, 2022

    Glioma Trial in United States (ONC201)

    Active, not recruiting
    • Glioma
    • San Francisco, California
    • +8 more
    Jul 14, 2022

    Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)

    Completed
    • Gliomas
    • New York, New York
      Columbia University Irving Medical Center
    Jun 30, 2022